PTH and Marchiafava-Bignami disease: According to clinical practice guidelines for the management of CKD-MBD from the Japanese Society for Dialysis Therapy (JSDT), dietary phosphorus restriction and/or the use of calcium-containing phosphorus binders and oral VDRA are recommended for controlling parathyroid hormone (PTH) levels in pre-dialysis patients.